Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
zhilong huoxue tongyu (044f0a)
- Development stage
- Unknown
- Lead developer
- Jiang Hanmei
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Zhilong Huoxue Tongyu is a Traditional Chinese Medicine (TCM) formulation, typically administered in capsule form, developed for the treatment of stable angina pectoris in patients with coronary heart disease (CHD). It is specifically indicated for the TCM phenotype of "Qi deficiency and blood stasis syndrome." The formulation's name suggests the inclusion of animal-derived components such as *Hirudo* (Shuizhi/Leech) and *Pheretima* (Dilong/Earthworm), which are traditionally used to promote blood circulation, resolve stasis, and improve microcirculation. The drug is currently being evaluated in Phase 2 clinical trials that utilize LC-MS metabolomics to analyze metabolic changes in serum, urine, and feces, aiming to provide a molecular basis for its therapeutic efficacy in cardiovascular disease.
- Brand names
- Zhilong Huoxue Tongyu Capsule
- Other names
- Zhidong Huoxue Tongyu capsuleZhulong Huoxue Tongyu capsuleZhilong Huoxue Tongyu
02
Targets
F2 (Thrombin)
Beyond the preview
Go deeper on zhilong huoxue tongyu (044f0a).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on zhilong huoxue tongyu (044f0a).